This inventor holds 1 USPTO granted patent and 10 published patent applications and 7 EPO patents. Top assignee: Metriopharm Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sara Schumann: Innovator in Pulmonary Disease Treatment
Introduction
Sara Schumann is a notable inventor based in Seddiner See, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of rare chronic inflammatory pulmonary diseases. Her innovative approach has led to the development of a unique pharmaceutical application.
Latest Patents
Sara Schumann holds 1 patent for her invention titled "Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of rare chronic inflammatory pulmonary diseases." This invention specifically relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione or its pharmaceutically acceptable salts, with a focus on the sodium salt, for therapeutic purposes.
Career Highlights
Sara is currently associated with Metriopharm AG, where she continues to advance her research and development efforts. Her work is pivotal in addressing unmet medical needs in the field of pulmonary diseases.
Collaborations
Sara collaborates with esteemed colleagues, including Wolfgang Brysch and Petra Schulz, to enhance the impact of her research and innovations.
Conclusion
Sara Schumann's contributions to the treatment of chronic pulmonary diseases exemplify her dedication to medical innovation. Her patent reflects a significant advancement in therapeutic options for patients suffering from these conditions.